Logo

People in the News: Lumora Names Reid as Chairman; Evogen Promotes St. Clair

Mar 01, 2013
Premium

Lumora has appointed Jim Reid as chairman.

Reid has spent more than 35 years in the bioscience and diagnostic industries in a number of positions at companies such as Organon, Bioscot, Roche, Chiron, and Trinity Biotech. He also holds a number of non-executive director positions, including with Sistemic, Ocutec, and BioFilm.

Evogen has named Richard St. Clair as vice president of commercialization.

St. Clair previously served as director of marketing and business development at Evogen. He will be responsible commercializing Evogen and Sceptor products for the healthcare, biodefense, and industrial markets.

St. Clair holds a BA in human biology from the University of Kansas and an MBA from Webster University.

Filed under

PCR
Evogen
Lumora
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.